Results 81 to 90 of about 69,031,262 (351)
Nature Reviews Microbiology, 2023 This study evaluates the efficacy of exogenous pegylated IFNλ in the treatment of patients with COVID-19.
openaire +2 more sources
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
European Journal of Medicinal Chemistry Reports, 2021 Antivirals already on the market and expertise gained from the SARS and MERS outbreaks are gaining momentum as the most effective way to combat the coronavirus outbreak.
V. Chavda +3 more
semanticscholar +1 more source
Annual Review of MedicineThe treatment for COVID-19 has evolved rapidly since the start of the pandemic and now consists mainly of antiviral and immunomodulatory agents. Antivirals, such as remdesivir and nirmatrelvir-ritonavir, have proved to be most useful earlier in illness (e.g., as outpatient therapy) and for less severe disease.
Hayden S, Andrews +2 more
openaire +2 more sources
Impact of COVID‐19 pandemic on lung cancer treatment scheduling
Thoracic Cancer, 2020 The current coronavirus disease 2019 (COVID‐19) pandemic is associated with a heavy burden on the mental and physical health of patients, regional healthcare resources, and global economic activity.
Kohei Fujita +5 more
doaj +1 more source
Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials
Вопросы вирусологии, 2022 COVID-19 (novel coronavirus disease 2019), caused by the SARS-CoV-2 virus, has various clinical manifestations and several pathogenic pathways. Although several therapeutic options have been used to control COVID-19, none of these medications have been ...
S. Bahadoram +6 more
doaj +1 more source
The Lancet, 2020 Background Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Fei Zhou +18 more
semanticscholar +1 more source
Knowledge and perception of COVID-19 and its treatment. A community-based survey in South Nigeria
Journal of Public Health in Africa, 2022 Background: Media channels increased COVID-19 pandemic uncertainty and disputes, hindering dissemination and acceptance of evidence-based health information.
Maureen Ntaji +3 more
doaj +1 more source
Неотложная медицинская помощь, 2021 Unified management plan and treatment strategy for COVID-19 patients are yet to be discovered. Many trials on COVID-19 interventions have been registered or are ongoing. In this article the results of large-scale clinical trials on COVID-19 treatment are
M. K. Vasilchenko +4 more
doaj +1 more source
Azvudine (FNC): a promising clinical candidate for COVID-19 treatment
Signal Transduction and Targeted Therapy, 2020 A very recent work published in Advanced Science by our group reveals that 2′-deoxy-2′-β-fluoro-4′-azidocytidine (Azvudine, FNC), a clinical candidate originally developed for HIV treatment, has entered clinical trial in China for evaluating its efficacy
Bin Yu, Jun-Biao Chang
semanticscholar +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann +8 more
wiley +1 more source